Angiomax Patent Dispute: On-Sale Bar Applies To Distribution Agreement

Hospira's generic does not infringe The Medicine Company's patented method of making Angiomax, US Federal Circuit finds, but leaves question of  whether TMC's distribution agreement covers manufacturing process for the district court to decide.